Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Gross Profit: 2009-2024

Historic Gross Profit for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $20.8 million.

  • Cumberland Pharmaceuticals' Gross Profit fell 17.70% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year increase of 25.70%. This contributed to the annual value of $20.8 million for FY2024, which is 1.21% down from last year.
  • Cumberland Pharmaceuticals' Gross Profit amounted to $20.8 million in FY2024, which was down 1.21% from $21.1 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Gross Profit's 5-year high stood at $25.4 million during FY2022, with a 5-year trough of $20.8 million in FY2024.
  • In the last 3 years, Cumberland Pharmaceuticals' Gross Profit had a median value of $21.1 million in 2023 and averaged $22.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first increased by 20.89% in 2022, then declined by 16.76% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Gross Profit (Yearly) stood at $22.7 million in 2020, then dropped by 7.52% to $21.0 million in 2021, then grew by 20.89% to $25.4 million in 2022, then declined by 16.76% to $21.1 million in 2023, then dropped by 1.21% to $20.8 million in 2024.